| Financial Year |
March 31 2023 |
| Monetary Funds |
61,135,577.95 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
230,396,769.00 |
| Advances to Suppliers |
34,991,365.99 |
| Other Receivables |
7,120,693.38 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
199,968,328.67 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
8,303,780.94 |
| Total Current Assets |
547,904,515.93 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
79,256,233.37 |
| Investment Properties |
10,241,507.44 |
| Fixed Assetes |
267,763,086.90 |
| Under-construction Projects |
1,500,986.68 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
107,481,347.08 |
| R&D expenses |
-- |
| Goodwill |
15,949,496.68 |
| Long-Term Deferred and Prepaid Expenses |
3,467,294.19 |
| Deferred Income Tax Assets |
47,884,886.41 |
| Other Non-Current Assets |
680,550.49 |
| Sub-Total of Non-Current Assets |
535,772,707.51 |
| Total Assets |
1,083,677,223.44 |
| Short-Term Loans |
117,522,052.76 |
| Trading Financial liabilities |
-- |
| Notes Payable |
27,210,500.00 |
| Accounts Payable |
104,959,143.69 |
| Accounts Received In Advance |
1,090,123.44 |
| Employee Compensation Payable |
9,333,747.51 |
| Taxes Payable |
4,404.80 |
| Interest Payable |
7,924,367.70 |
| Dividend Payable |
-- |
| Other payables |
206,943,680.44 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
15,857,713.80 |
| Other Current Liabilities |
6,394,726.19 |
| Sub-Total of Current Liabilities |
515,556,028.04 |
| Long-term Loans |
28,400,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
5,092,524.24 |
| Deferred Income Tax Liabilities |
588,217.65 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
51,051,610.90 |
| Total Liabilities |
566,607,638.94 |
| Paid-In Capital(Or Share Stock) |
260,000,000.00 |
| Capital Surplus |
533,914,980.36 |
| Surplus Reserve |
59,312,785.49 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-404,208,260.71 |
| Minority Stockholder's Interest |
50,410,255.44 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
466,659,329.06 |
| Owner's Equity（Stockholder's Equity） |
517,069,584.50 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,083,677,223.44 |
